Profil
David R.
Seaton served as the Acting CEO, Chief Financial Officer & Secretary at MEI Pharma, Inc. from 2009 to 2010.
Prior to that, he was the Chief Financial Officer at Kazia Therapeutics Ltd.
from 1999 to 2010.
He also served as the Chief Financial Officer & Secretary at Glycotex, Inc. Mr. Seaton received his undergraduate and graduate degrees from The University of New South Wales.
Anciens postes connus de David R. Seaton
| Sociétés | Poste | Fin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Directeur Financier/CFO | 18/06/2010 |
| MEI PHARMA, INC. | Directeur Financier/CFO | 21/06/2010 |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Directeur Financier/CFO | - |
Formation de David R. Seaton
| The University of New South Wales | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |